An FDA study in two groups of children shows that MED-EL cochlear implants are safe and effective for children seven-71 months old with bilateral SNHL who cannot hear well enough with hearing aids.
The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants ...
The SYNCHRONY Cochlear Implant (CI) System, was awarded 1 st place (Gold) in the Auditory Implant Category. The industry-leading innovation of a diametrically-opposed magnet shattered traditional CI ...
MED-EL’s cochlear implants are now FDA-approved in children seven months and older with bilateral sensorineural hearing loss ...
MED-EL USA announced today that, together with Starkey, DualSync technology was awarded a Hearing Technology Innovator Award in the Bimodal Hearing Category. The annual awards program, hosted by ...
INNSBRUCK, Austria--(BUSINESS WIRE)--Hearing loss is on the rise, with the World Health Organization (WHO) estimating that 1 in 5 people already live with hearing loss. Many face daily challenges in ...
Medical technology company MED-EL announced Thursday that the US Food and Drug Administration has approved expanding the use of its Synchrony cochlear implants to children as young as 7 months who ...
To mark World Hearing Day, a partnership between two international leaders in healthcare has been announced, which will see the Evercare Group and MED-EL join forces to provide people in Nigeria, ...
Innsbruck- April 19 2012. UAE-based physicians will present information about their experiences with MED-EL Hearing Implant Systems at the 9th Annual Middle East Update in Otolaryngology Conference ...
The sound of music or a loving voice: The value of hearing in our lives is frequently overlooked by people who are able to hear, but for those who are deaf, the world remains silent. As a hearing ...
Dublin, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The "Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide 2017 to 2023" report from Wintergreen Research, Inc has been added ...